Supplements

Is Multivitamin Good for You Worth Taking? A Look at the Clinical Trials

More than half of American adults take a multivitamin every day, yet landmark clinical trials keep returning a complicated verdict. The evidence isn't that vitamins don't work — it's that one-size-fits-all dosing ignores the biochemical gaps that actually matter for your body.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
multivitaminspersonalized supplementsvitamin D3magnesium glycinateiron deficiencyB12

Is Multivitamin Good for You? A Look at the Clinical Trials

More than half of American adults swallow a multivitamin each morning, making it the best-selling supplement category in the country — a market worth over $8 billion annually. Yet when researchers put standard multivitamins against placebo in long-duration randomized controlled trials, the results are far more nuanced than the label copy suggests. The honest answer to "is multivitamin good for you?" turns out to be: it depends on what you're deficient in, what dose you're getting, and whether those nutrients are in the right form.

This article breaks down what the clinical literature actually shows, which nutrients within a multivitamin formula have the strongest evidence, and why personalized nutrient targeting is increasingly how practitioners and platforms like Ones think about supplementation.

---

What the Major Clinical Trials Actually Say

The most cited evidence comes from a handful of large, well-designed trials:

The COSMOS-Mind Trial (2022) — A sub-study of the Cocoa Supplement and Multivitamin Outcomes Study, COSMOS-Mind followed 2,262 adults aged 65 and older for three years. The multivitamin group showed significantly better global cognition scores compared to placebo — an effect the authors estimated was equivalent to approximately 1.8 years of age-related cognitive protection (Baker et al., American Journal of Clinical Nutrition 2023; PMID: 36774172).

The Physicians' Health Study II (PHSII) — This randomized, double-blind trial followed 14,641 U.S. male physicians for over 11 years. Daily multivitamin use was associated with an 8% reduction in total cancer incidence compared to placebo (Gaziano et al., JAMA 2012; PMID: 23093172). Importantly, no significant effect on cardiovascular disease mortality was detected, which aligns with the broader body of evidence.

The USPSTF 2022 Review — The U.S. Preventive Services Task Force completed a comprehensive review of multivitamin supplementation and concluded there was insufficient evidence to recommend for or against their use for primary prevention of cancer or cardiovascular disease in non-pregnant, non-institutionalized adults (Mangione et al., JAMA 2022; PMID: 35727271). Crucially, the task force noted that the heterogeneity of products and study populations made pooled conclusions difficult.

What unites these findings: multivitamins show modest, inconsistent benefit in populations that are largely nutrient-replete. Benefits sharpen considerably when people are actually deficient. A generic multi is a blunt instrument; it delivers iron to someone whose ferritin is already optimal, while possibly delivering an inadequate dose of Vitamin D to someone sitting at 18 ng/mL.

---

Is Iron Good for You — and Do You Actually Need It in a Multi?

Iron is one of the most instructive examples of why formulation matters. For premenopausal women, iron deficiency is common — roughly 14% of women aged 12–49 in the U.S. are iron deficient according to NHANES data (Camaschella, New England Journal of Medicine 2015; PMID: 26244931). For postmenopausal women and most adult men, however, excess iron is a real concern: surplus iron generates reactive oxygen species through Fenton chemistry and has been associated with increased cardiovascular and metabolic risk.

Many standard multivitamins contain 18mg of iron — the RDA for premenopausal women — regardless of who is taking them. A 55-year-old man with adequate serum ferritin has no clinical need for that iron, and a 28-year-old woman with a ferritin of 8 ng/mL probably needs a targeted therapeutic dose, not 18mg mixed with 25 other compounds.

This is precisely why blood work context changes the conversation. Understanding how low ferritin affects energy and cognitive function before choosing any iron-containing formula is a better starting point than defaulting to a one-size-fits-all product.

The evidence on iron is also closely tied to B-vitamin status — which brings us to the next consideration.

---

Can You Take Iron and B12 Together?

This is a frequently searched question and it reflects a real concern — though the mechanism is often misunderstood. The short answer is: yes, you can take iron and B12 together, and there is no documented clinical interaction that prevents co-administration in standard oral supplementation.

The confusion likely stems from the fact that both iron deficiency anemia and B12 deficiency anemia present with similar symptoms — fatigue, pallor, cognitive fog — which leads people to wonder if one blocks the other. In reality, vitamin B12 (as methylcobalamin or adenosylcobalamin) is a water-soluble vitamin with a completely different absorption pathway than non-heme iron. B12 is absorbed via intrinsic factor in the terminal ileum; iron is primarily absorbed in the duodenum via DMT1 transporters.

What does affect B12 absorption is gastric acid. Proton pump inhibitors (PPIs) significantly impair B12 absorption over time, and older adults with achlorhydria are at elevated B12 deficiency risk regardless of dietary intake (NIH Office of Dietary Supplements, Vitamin B12 Fact Sheet). Iron absorption, on the other hand, is enhanced by vitamin C and inhibited by calcium, phytates, and polyphenols — not by B12.

For someone with both low ferritin and suboptimal B12 (a combination frequently seen in people following plant-based diets), addressing both within the same formula is entirely reasonable. What matters more is the form and dose: methylcobalamin tends to show superior tissue retention compared to cyanocobalamin in some populations, and iron as ferrous bisglycinate causes less gastrointestinal distress than ferrous sulfate at equivalent doses (Szarfarc et al., Archivos Latinoamericanos de Nutricion 2001).

---

Is Turkesterone Good for You? Understanding Novel Actives That Won't Appear in Standard Multis

Beyond the classic micronutrient discussion, a growing segment of supplement users is asking about compounds like turkesterone — an ecdysteroid derived from Ajuga turkestanica — in the context of muscle protein synthesis and athletic performance.

So is turkesterone good for you? The preliminary evidence is intriguing but limited. Ecdysteroids are proposed to interact with estrogen receptor beta (ERβ) and potentially stimulate muscle protein synthesis via the PI3K/Akt/mTOR pathway. A 2019 study by Isenmann et al. in Archives of Toxicology found that ecdysterone (a related compound) at 12mg/day for 10 weeks produced significantly greater increases in muscle mass compared to placebo in resistance-trained men (Isenmann et al., Archives of Toxicology 2019; PMID: 30980087). Turkesterone specifically has less human trial data, and the available evidence is largely preclinical.

Where this connects to the multivitamin conversation: standard multivitamins are not the vehicle for performance-oriented actives like turkesterone. These compounds require targeted dosing, context about training load, hormonal baseline, and health goals — exactly the kind of context that determines whether an active belongs in your formula at all. Ones' catalog focuses on clinically validated actives with human trial data; ingredients like Ashwagandha KSM-66 at 600mg and Rhodiola Rosea have substantially stronger evidence bases for stress adaptation and physical performance than turkesterone does at this point in the literature.

If you're interested in adaptogenic support for performance or resilience, the clinical evidence for ashwagandha KSM-66 is a more thoroughly documented starting point.

---

What Is Melatonin Good For — and Why Sleep Affects Whether Your Nutrients Even Work

Melatonin sometimes appears in comprehensive wellness formulas, and understanding what melatonin is good for helps clarify where it fits relative to a multivitamin.

Melatonin is primarily indicated for circadian rhythm regulation — jet lag, shift work disorder, and delayed sleep phase syndrome — not as a sedative. Meta-analyses confirm it reduces sleep-onset latency by roughly 7–12 minutes and modestly improves sleep quality in circadian disruption contexts (Ferracioli-Oda et al., PLOS ONE 2013; PMID: 23691095). Doses in clinical trials range from 0.5mg to 5mg; higher doses do not appear to produce proportionally greater benefit and may blunt endogenous melatonin production over time.

The reason sleep quality belongs in a multivitamin conversation is mechanistic: nutrient absorption and utilization are significantly affected by sleep. Growth hormone secretion during slow-wave sleep drives the anabolic use of amino acids and certain micronutrients. Magnesium, in particular, plays a bidirectional role — it supports GABA receptor function to promote sleep, and sleep disruption depletes magnesium status over time. Exploring magnesium glycinate's effects on sleep quality reveals why this mineral is one of the most consequential gaps in standard multivitamin formulas, which typically include magnesium oxide — a poorly absorbed form.

---

The Core Problem With Generic Multivitamins: Forms, Doses, and Context

Even if we accept that certain nutrients in a multivitamin are beneficial, generic products face three structural problems:

ProblemExampleClinical Implication
Wrong formMagnesium oxide (~4% absorbed) vs. magnesium glycinate (~80% absorbed)Negligible benefit from oxide at standard doses
UnderdosingVitamin D at 400 IU vs. therapeutic 2,000–5,000 IUInsufficient to correct deficiency at 400 IU
Overdosing where not needed18mg iron in men with replete ferritinOxidative stress risk with no benefit
Missing interactionsVitamin D without K2 (MK-7)D3 raises calcium absorption; K2 directs calcium to bone, not arteries
No biomarker contextSame formula for everyoneNo adjustment for individual SNPs, gut absorption, or lab values

The vitamin D3 and K2 synergy issue is particularly instructive: studies suggest that adequate vitamin K2 is necessary to activate matrix Gla protein and osteocalcin — proteins that help ensure calcium deposited by vitamin D lands in bone rather than arterial walls. A multivitamin that includes D3 at a meaningful dose without K2 as MK-7 is delivering an incomplete formula.

---

How Ones Addresses This

Ones takes a fundamentally different approach to the "is multivitamin good for you" question by rejecting the premise that a fixed combination product can serve everyone. Instead, the platform analyzes your blood work, wearable data, and health history to identify your actual deficiencies and goals, then builds a custom capsule formula from a curated catalog of clinically validated ingredients.

Three specific examples of how this differs from a standard multi:

Vitamin D3 + K2 (MK-7): Ones includes these together, with D3 dosed to bring blood levels to an optimal range (typically 2,000–5,000 IU depending on baseline labs) alongside K2 as MK-7 — the longer-acting form supported by studies on arterial calcification and bone mineral density (Knapen et al., Osteoporosis International 2013; PMID: 23525894).

Magnesium Glycinate (as part of the Magnesium Complex System Blend): Rather than magnesium oxide, Ones uses glycinate — a chelated form with superior bioavailability and documented effects on sleep latency and muscle recovery. The Magnesium Complex System Blend is one of Ones' 18 proprietary System Supports, calibrated to your capsule budget across 6, 9, or 12-capsule plans.

Omega-3 (EPA/DHA): Generic multivitamins contain little to no omega-3. Ones includes pharmaceutical-grade fish oil dosed to clinically relevant EPA/DHA levels — important context given that EPA and DHA have distinct biological roles, with EPA more relevant to inflammatory signaling and DHA to neurological structure. Understanding the omega-3 EPA DHA ratio and how it applies to your specific health goals is part of how Ones personalizes this ingredient.

Comparison to other platforms:

FeatureOnesThorneRitualViomeFunction Health
Blood work integration Full panel analysisPartial (gut only) Testing only
Custom capsule formula
Clinical ingredient dosesPartialPartialN/A
Wearable data integration
System Blends (proprietary) 18 blends

---

Key Takeaways

  • Multivitamins show modest benefit in nutrient-replete populations — clinical trials like COSMOS-Mind and PHSII suggest real but limited advantages, primarily in cognitive protection and modest cancer risk reduction.
  • The form and dose of each nutrient matters more than the label claim — magnesium oxide, cyanocobalamin, and low-dose D3 are common cost-cutting shortcuts with significantly less clinical impact than their higher-quality counterparts.
  • Iron belongs in a formula only when deficiency is confirmed — supplementing iron without knowing your ferritin level can cause harm for iron-replete individuals; blood work context is essential.
  • Iron and B12 can safely be taken together — they use separate absorption pathways; the more relevant concern is the form of B12 (methylcobalamin vs. cyanocobalamin) and whether gastric acid is adequate for absorption.
  • Melatonin supports circadian regulation, not general sleep quality — at 0.5–3mg, it's useful for jet lag and shift work; its inclusion in a formula should reflect a specific sleep-phase issue, not a general request for "better sleep."
  • Personalized formulas outperform generic multis when biomarker data drives the protocol — platforms that integrate lab results, wearable data, and health goals can target deficiencies precisely, skip unnecessary actives, and dose clinically relevant ingredients at ranges the research actually supports.

Always consult a qualified healthcare provider before starting any supplement regimen, particularly if you are managing a diagnosed condition, taking prescription medications, or are pregnant or breastfeeding.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading